Alvimopan Capsule
Product Images NDC 0591-2312

4 FDA label images from Actavis Pharma, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Alvimopan (NDC 0591-2312). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

1 (Image 1)

1 (Image 1)
Chemical structure of Alvimopan including its molecular arrangement and the notation for two water molecules of crystallization (dihydrate). The diagram shows the detailed chemical bonds and groups characteristic of Alvimopan.*
FDA Label Image

1 (Image 2)

1 (Image 2)
A line graph comparing the estimated probability of achieving an endpoint over time (hours after end of surgery) between Alvimopan and placebo groups. The x-axis represents hours after surgery, ranging from 0 to 264, and the y-axis shows the estimated probability, from 0.0 to 1.0. The graph includes two lines: a dashed line for Alvimopan and a solid line for placebo, illustrating that Alvimopan has a higher probability of achieving the endpoint over time.*
FDA Label Image

1 (Image 3)

1 (Image 3)
A line chart showing the estimated probability of achieving endpoint over time, comparing Alvimopan and placebo. The x-axis represents hours after the end of surgery, and the y-axis shows the estimated probability. The dashed line for Alvimopan rises more quickly and plateaus higher than the solid line for placebo, indicating a higher probability over time with Alvimopan.*
FDA Label Image

1 (Image 4)

1 (Image 4)
Packaging label for Alvimopan Capsules 12 mg, hospital use only. The label indicates 30 unit-dose capsules (6 x 5), with storage instructions, manufacturer information including Watson Pharma Private Ltd. in India, and Teva Pharmaceuticals USA, Inc. The packaging features the Teva logo and includes the product's NDC 0591-2312-15.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.